Clinical trials
Ventilator Associated Pneumonia clinical trials
Below are recruiting ventilator associated pneumonia clinical trials, each written for real people, not researchers. We’re tracking 53 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06966817Enrolling by invitation
Mouth care solutions for ventilator patients in the ICU
This study tests two different mouth-care solutions for patients on breathing machines, to see if they can prevent pneumonia and improve mouth health in intensive care.
AnkaraAges 18–90 - NCT06834971Recruiting
Inhaled colistin to prevent pneumonia in ventilated patients
This trial tests if inhaling a medication called colistin can prevent ventilator-associated pneumonia (a lung infection) in patients who are on a breathing machine. It aims to reduce the risk for those at high risk of getting an infection from drug-resistant bacteria.
Jinan, ShandongAges 18 years+ - NCT06819462Recruiting
Inhaled colistin to prevent ventilator pneumonia in brain injury patients
This trial tests whether giving an inhaled antibiotic called colistin can prevent pneumonia in patients with brain injuries who are on ventilators. If effective, it could reduce lung infections and improve recovery.
Nanjing, JiangsuAges 18–80 - NCT06743529Recruiting
Antibiotics right away or later for lung infections from a breathing machine
This study looks at when to start antibiotics for a lung infection you may have gotten while on a breathing machine. It compares starting them right away versus waiting for the test results to be sure you need them.
Angers, FranceAges 18 years+ - NCT06624540Recruiting
Reducing pneumonia in ICU patients through evidence-based nursing
This trial tests whether teaching nurses proven methods can lower the rate of ventilator-associated pneumonia (a lung infection from breathing machines) in intensive care. It aims to improve care for patients on ventilators.
DhakaAges 18 years+ - NCT06607055Recruiting
Immune markers in ICU patients with pneumonia
This study looks at how the immune system reacts in ICU patients on a ventilator who have pneumonia. By measuring immune markers, the researchers hope to better understand and predict complications like ventilator-associated pneumonia.
Aix-en-ProvenceAges 18 years+ - NCT06554327Recruiting
Rapid test for lung infection in ICU patients on a ventilator
This trial uses a rapid test (PCR) to check for bacteria in your lung fluid, so doctors can pick the right antibiotics faster. It's for ICU patients on a breathing machine who may have a lung infection.
ReimsAges 18 years+ - NCT06134492RecruitingPhase 3
Acyclovir for pneumonia patients with HSV-1 on breathing support
This trial tests whether acyclovir, an antiviral drug, can help patients with pneumonia who are on breathing support and have herpes simplex virus in their lung fluid. The goal is to see if it improves recovery.
Freiburg im Breisgau, Baden-WurttembergAges 18 years+ - NCT06087536RecruitingPhase 2
Trial of OMN6 for hospital-acquired Acinetobacter pneumonia
This trial tests a new antibiotic called OMN6 for people with a serious lung infection (pneumonia) caught in the hospital or from a breathing machine, caused by a hard-to-treat bacteria (Acinetobacter). The goal is to see if OMN6 is safe and how the body processes it.
AthensAges 18–99 - NCT05843786RecruitingPhase 3
Interferon gamma for ventilator pneumonia in ICU
This trial tests whether a medicine called interferon gamma can improve outcomes in adults with a first episode of pneumonia that develops after being on a ventilator in the ICU. It is designed for specific ICU timing, infection severity, and immune marker levels, and it compares treatment on top of standard care.
LimogesAges 18 years+ - NCT05719259Recruiting
Study on pneumonia from breathing machines in the ICU
This study watches patients in the intensive care unit (ICU) who are on a breathing machine (ventilator) to learn more about pneumonia that can happen from the machine. The goal is to understand how to better prevent and treat this infection.
TiranaAges 18 years+ - NCT05405491Recruiting
DNA test to guide antibiotic use for pneumonia in ICU patients
This study tests whether using a DNA test on lung fluid can help doctors choose better antibiotics for pneumonia in ICU patients with weakened immune systems. It may lead to more effective treatment and fewer side effects.
LilleAges 18 years+ - NCT05117125Recruiting
Testing for markers in early ventilator lung infections
This study looks at changes (biomarkers) in the blood or other samples from people on a breathing machine. It may help doctors detect ventilator-associated pneumonia earlier and tailor treatment sooner.
DrammenAges 18 years+ - NCT07004049RecruitingPhase 4
Testing combinations for resistant Gram-negative infections
This study tests different antibiotic combinations for severe infections caused by hard-to-treat Gram-negative bacteria (like Pseudomonas or Acinetobacter). The goal is to find the best treatment for bloodstream infections or pneumonia that started in the hospital.
Brisbane, QueenslandAges 18 years+ - NCT06073834Recruiting
Lung infection study in ICU patients
This trial tests a new way to better understand lung infections in very sick ICU patients. It looks at people with septic shock, severe trauma, or major burns to see if an infection is the cause.
LyonAges 18 years+ - NCT07181824Recruiting
Diagnosing pneumonia in ventilated ICU patients
This trial looks at how well doctors followed current guidelines to diagnose ventilator-associated pneumonia (a lung infection from a breathing tube) in ICU patients between 2022 and 2024. It aims to improve future care.
Corbeil-Essonnes, FranceAges 18 years+ - NCT07129174Recruiting
Lung bacteria changes in neurosurgery ICU patients with breathing tubes
This study looks at how tiny organisms in the lungs (the lung microbiome) change in neurosurgery patients who need a breathing tube in the ICU. It aims to see if these changes affect recovery or outcomes.
Beijing, Beijing MunicipalityAges 18 years+ - NCT05591924Recruiting
Bioinformatics study in adults with very early severe ICU illness
This trial studies how early severe illness in the ICU can be understood and tracked using health data (bioinformatics/informatics). It may help improve care decisions for people who arrive to the ICU soon after an emergency department visit.
London, OntarioAges 18 years+ - NCT06000761Recruiting
Mouth care with human milk for premature babies
This trial is testing whether giving gentle mouth care with human milk to very premature babies in the NICU can help their health. It focuses on babies born early and with low birth weight whose mothers can provide milk.
Gainesville, FloridaAges 1 hour–3 days - NCT05915663Recruiting
Choosing where to place a stomach tube
This study looks at whether different placement locations for a stomach (gastric) tube can lower the risk of pneumonia in people on a breathing machine. It’s aimed at patients expected to need ventilation for more than 48 hours.
AngersAges 18 years+ - NCT05767671Recruiting
Breathing tube patients in ICU tested for lung inflammation treatment
This trial studies whether changing immune cells in the lungs (using a procedure called MiniBAL) can improve outcomes in adults who are critically ill and on a breathing tube. It may help doctors better manage acute lung injury by targeting inflammation early in the ICU stay.
Denver, ColoradoAges 18–99 - NCT04987840Enrolling by invitation
Hospital program to reduce unnecessary lung culture tests in kids
This trial studies a hospital quality-improvement program that aims to use fewer “respiratory culture” tests in pediatric intensive care units (PICUs). It may help reduce unnecessary testing while maintaining good care for critically ill children.
Baltimore, MarylandAges Any age - NCT07052604Recruiting
Antibiotic treatment for a rare pneumonia in ICU patients
This study looks at how well antibiotics work for pneumonia caused by a specific bacterium (Stenotrophomonas maltophilia) in patients who are on breathing machines in the intensive care unit (ICU). It will help doctors choose the best treatment.
Saint-Denis, FranceAges 18 years+ - NCT07233837Recruiting
Cleaning ICU surfaces with hydrogen peroxide and UV light
This trial tests a new way to clean surfaces in intensive care units (ICUs) using hydrogen peroxide and ultraviolet (UV) light. It aims to see if this method reduces infections in patients.
Barbalha, CearáAges 18 years+
Hear when a new Ventilator Associated Pneumonia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for ventilator associated pneumonia?
- Yes. Clin2 currently lists 53 recruiting ventilator associated pneumonia studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a ventilator associated pneumonia trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a ventilator associated pneumonia trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.